Digital Subtraction Angiography
Diagnostic TestCompare optical coherence tomography lesion sizing and characteristics compared to traditional digital subtraction angiography
NCT Number: NCT04748965
This study aims to investigate the utilization of intravascular imaging in treatment of tibial vessels in peripheral artery disease and critical limb ischemia (CLI). The primary goal is to compare optical coherence tomography (OCT) with traditional digital subtraction angiography (DSA) in determining best treatment strategy and vessel optimization, in an effort to improve long term patency and successful wound healing in CLI. Secondary comparison with intravascular ultrasound (IVUS) is undertaken when clinically feasible. The hypothesis is that the adjunctive use of intravascular imaging will affect vessel sizing and anticipated treatment modalities, and therein affect the long term primary patency rates.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
University Hospitals Ahuja Medical Center, Beachwood, Ohio, United States
This is a prospective, nonrandomized trial to investigate the adjunctive use of intravascular imaging in tibial vessel interventions. The evaluation of OCT is primarily to: (a) establish feasibility and reproducibility in below-the-knee vessels, (b) determine the optimal protocol imaging to produce the optimal clear image frame and clear image length, (c) provide detailed lesion characteristics of tibial disease, (d) assess for luminal gain post-intervention. Operator-determined sizing will be compared against University Hospitals Core Imaging Laboratory assessment of OCT, IVUS (when applicable), and quantitative vessel analysis (QVA).
Subjects will follow up per routine care with corresponding ankle-brachial index and toe-brachial index at 1, 3, 6, and 12 months or as clinically indicated. Wound and amputation data will be collected at the pre-procedural visit and with each subsequent visit. Wound care will be managed by our wound care associates in podiatry, vascular medicine, vascular surgery, or plastic surgery.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Compare optical coherence tomography lesion sizing and characteristics compared to traditional digital subtraction angiography
Time frame: 12 months
To develop a protocolized, reproducible technique to maximize the Clear Image Length (CIL) on 75 mm pullbacks using 100% contrast in the tibial arteries. The goal is to compare intravascular ultrasound (IVUS) and optical coherence tomography (OCT) with traditional digital subtraction angiography (DSA) in determining best treatment strategy and vessel optimization, in an effort to improve long term patency and successful wound healing in CLI. The hypothesis is that the adjunctive use of intravascular imaging will affect vessel sizing and anticipated treatment modalities, and therein affect the long term primary patency rates.
Time frame: 12 months
CIL in 100% contrast versus 50% contrast/heparinized saline mixture
Time frame: 12 months
minimal lumen area (mm^2)
Time frame: 12 months
reference vessel diameter (mm)
Time frame: 12 months
reference vessel area (mm^2)
Time frame: 12 months
percentage stenosis (%) on pre-intervention imaging
Time frame: 12 months
Percentage composition of calcium, fibrous, or lipid plaque (%)
Time frame: 12 months
Calcium arc (degree)
Time frame: 12 months
depth of calcium (micron)
Time frame: 12 months
depth of fibrous cap (micron)
Time frame: 12 months
Measurement of attenuation coefficient (μ OCT) to quantify the strength of interaction of light and tissue
Time frame: 12 months
Post-intervention luminal gain (%), plaque modification, and dissections
Time frame: 12 months
Reduction in calcium depth (%) if atherectomy is performed
Time frame: 12 months
Qualitative description of dissections seen on post-intervention imaging
University Hospitals Cleveland Medical Center
Other
Acronym: iVEST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05009602
Arterial Occlusive Diseases, Arteriosclerosis
Basildon, United Kingdom
View Trial DetailsNCT02807779
Arterial Occlusive Diseases, Arteriosclerosis
San Francisco, California, United States
View Trial DetailsNCT02863926
Arterial Occlusive Diseases, Arteriosclerosis
Indianapolis, Indiana, United States
View Trial DetailsNCT04304105
Arterial Occlusive Diseases, Arteriosclerosis
Los Angeles, California, United States
View Trial Details